Home › Companies › Biotechnology, Health Care, Health Diagnostics, Therapeutics › AsclepiX Therapeutics
AsclepiX Therapeutics
AsclepiX Therapeutics is a biotech company that develops novel therapeutics to revolutionize the treatment of retinal diseases and cancer.
AsclepiX Therapeutics operates in biotechnology, health care, health diagnostics, therapeutics based in Greater Baltimore-Maryland Area, East Coast, Southern US, founded in 2011.
AsclepiX Therapeutics is positioned in biotechnology, health care, health diagnostics, therapeutics, a segment that rewards a clear, focused offering.
Greater Baltimore-Maryland Area, East Coast, Southern US is where the company is located.
Its current recorded stage is Series_A.
The company reports a headcount in the c_00011_00050 range.
Public records show total funding of about $50M.
| Sector | Biotechnology, Health Care, Health Diagnostics, Therapeutics |
|---|---|
| Headquarters | Greater Baltimore-Maryland Area, East Coast, Southern US |
| Founded | 2011 |
| Employees | c_00011_00050 |
| Stage | series_a |
| Total funding | $50,000,000 |
Website: asclepix.com
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account